TL;DR
This study uses targeted next-generation sequencing to identify novel genetic mutations in the SLC2A9 and SLC22A12 genes associated with hypouricemia (abnormally low uric acid levels) in a large Chinese cohort. The findings reveal six rare mutations, two of which are newly reported, and provide a more comprehensive understanding of the genetic landscape of hypouricemia in this population.
What Problem Does This Paper Address?
Hypouricemia, characterized by low serum uric acid (SUA) levels, is often overlooked in clinical practice despite its association with various health issues, including acute kidney injury, kidney stones, and even neurodegeneration. While genetic defects in renal urate transporters, primarily SLC2A9 and SLC22A12, are known causes of hereditary renal hypouricemia (hRHUC), most previous studies have focused on case reports or small cohorts, often using traditional Sanger sequencing. This approach can be time-consuming and may miss complex genetic interactions. Furthermore, the genetic basis of hypouricemia in the Han Chinese population remains less understood, with limited comprehensive mutation spectrum analyses. This paper aims to address this gap by employing a more efficient next-generation sequencing (NGS) approach to identify and analyze mutations in SLC2A9 and SLC22A12 across a larger, well-defined cohort of hypouricemic individuals, hyperuricemic individuals, and normal controls.
Methods
The researchers utilized an amplicon-targeted next-generation sequencing (NGS) approach. This method involves designing specific DNA primers to amplify (replicate) only the regions of interest – in this case, all exon and partial untranslated regions (UTRs) of the SLC2A9 and SLC22A12 genes. These amplified fragments were then prepared into sequencing libraries with unique barcoding for multiplexing. High-throughput sequencing was performed using an Illumina Xten platform to generate paired-end reads.
Following sequencing, a series of bioinformatic analyses were conducted:
- Read trimming and alignment: Raw sequencing reads were cleaned of adapter sequences using Trimmomatic and then aligned to the human genome reference sequences for SLC2A9 and SLC22A12 using BWA.
- Variant calling and quality control: Variants (differences in DNA sequences) were identified using GATK HaplotypeCaller. Stringent quality control measures were applied, including filtering based on read depth, mapping quality, and base quality, to ensure the reliability of the identified variants.
- Annotation: Identified variants were annotated using Annovar to determine their potential impact (e.g., missense, frameshift, synonymous).
- Statistical analysis: Comparative analyses were performed to assess the association of identified variants with hypouricemia and hyperuricemia (HUA). This included Hardy-Weinberg equilibrium (HWE) testing in controls, chi-square tests for categorical data, and odds ratios (ORs) with 95% confidence intervals for association analyses. Linkage disequilibrium (LD) analysis was also conducted using Haploview.
Datasets
The study utilized three cohorts for sequencing and analysis:
- Hypouricemia cohort: 31 individuals diagnosed with hypouricemia (serum uric acid ≤ 2 mg/dl).
- Normal control cohort: 280 individuals with normal serum uric acid levels (3–6 mg/dl).
- Hyperuricemia (HUA) cohort: 288 individuals with hyperuricemia (serum uric acid > 7 mg/dl).
Demographic and clinical data, including age, sex, body mass index (BMI), blood pressure, glucose, triglyceride, cholesterol, BUN, creatinine, and SUA levels, were collected and analyzed for these cohorts.
Key Insights and Ideas
- Targeted NGS for efficiency: The study highlights the effectiveness of amplicon-targeted NGS for efficiently and cost-effectively identifying mutations in specific genes, offering an advantage over traditional methods for larger cohorts.
- Comprehensive mutation spectrum: This research provides the first comprehensive mutation spectrum of hypouricemia in a large Han Chinese cohort, expanding our understanding beyond previously studied populations.
- Rare variants as key players: The findings strongly suggest that rare, nonsynonymous variants in SLC2A9 and SLC22A12 are significantly associated with hypouricemia, while common variants showed no significant effects.
- Sex-specific associations: Interestingly, some identified mutations showed significant associations with hypouricemia specifically in males or females, indicating potential sex-dependent genetic influences.
- Complexity of genotype-phenotype correlation: The study notes that the severity of hypouricemia doesn't always directly correlate with the type of mutation (e.g., heterozygous vs. homozygous), suggesting a complex interplay of genetic and potentially other factors.
Key Results
- A total of 84 high-quality variants were identified across the three cohorts.
- Six rare single nucleotide variations (SNVs) were found to be significantly associated with hypouricemia and were absent in HUA and normal controls:
- SLC2A9: p.T211 and p.G13D
- SLC22A12: p.W50fs, p.Q382L, p.V547L, and p.E458K
- Two of these mutations, p.G13D in SLC2A9 and p.V547L in SLC22A12, were newly reported.
- The rare mutation carrier rate in the hypouricemia group (19.3%) was significantly higher than in the normal control group (2.14%), with an odds ratio of 10.96 (p = 3.19E-7).
- Aggregated rare mutations conferred no significant effect on HUA susceptibility.
- Notably, two previously reported hypouricemia causative mutations (SLC22A12: p.R90H and SLC22A12: p.W258X) were found in normal controls rather than in hypouricemic individuals in this cohort.
Limitations and Future Work
- Low detection rate of causative mutations: The study identified causative mutations in only 6 out of 31 hypouricemic subjects, which is a lower rate compared to some previous studies. The authors suggest this could be due to the cohort being community-based and potentially including secondary hypouricemia cases or individuals with xanthinuria.
- Potential for false positives: The authors acknowledge that some of the identified rare SNVs might be false positives, and a larger sample size and functional experiments are needed for replication and confirmation.
- Limited clinical data: The study lacked detailed past medical history for participants, such as onset of AKI, urolithiasis, and medication history, which could influence SUA concentrations.
- Focus on two genes: The study focused solely on SLC2A9 and SLC22A12. The authors suggest that other genes might also contribute to hypouricemia in the Han Chinese population, and whole-genome studies are recommended to identify new causal genes and mutations.
- Functional studies needed: While statistical associations were found, functional studies are crucial to definitively confirm the urate transportation activity and pathophysiological role of the identified variants.
- Sex-specific analysis limitations: The authors note that sample size might have limited the statistical power for some sex-specific analyses.
Summary updated